Sanofi-Aventis recalls 30 batches of Lovenox

February 20, 2006

Sanofi-Aventis has voluntarily recalled 30 batches of syringes containing the anticoagulant Lovenox (enoxaparin), because of a problem related to the syringe-filling process. The company said the recalled syringes may contain too much of the active ingredient enoxaparin.

Sanofi-Aventis recalls 30 batches of Lovenox

Sanofi-Aventis has voluntarily recalled 30 batches of syringes containing the anticoagulant Lovenox (enoxaparin), because of a problem related to the syringe-filling process. The company said the recalled syringes may contain too much of the active ingredient enoxaparin. The recalled batches were filled at a single facility and delivered to countries in Europe, Latin America, Asia, and Africa. Enoxaparin is sold under the name Clexane in some countries. The firm stressed that enoxaparin is not the subject of the recall.

To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.